MetLife (MET) shares have recently declined by nearly 4% over the past month, raising questions about its current valuation despite a strong 87.3% total shareholder return over five years. The stock is currently trading below analyst price targets and appears undervalued at $93 according to Simply Wall St's fair value calculations, driven by assumptions about future margins and revenue growth supported by digital transformation. Investors are weighing the potential upside against risks such as persistent low interest rates or slow technology adoption.

大都会人寿

<p>大都会人寿（MetLife，股票代码：MET）最近一个月的股价下跌了近 4%，引发了人们对其当前估值的质疑，尽管在过去五年中其总股东回报率达到了 87.3%。根据 Simply Wall St 的公允价值计算，该股票目前的交易价格为 93 美元，低于分析师的目标价，似乎被低估，这一估值是基于对未来利润率和收入增长的假设，这些假设得到了数字化转型的支持。投资者正在权衡潜在的上涨空间与持续低利率或技术采用缓慢等风险</p>

大都会人寿 (MET)：在近期股价下跌后探讨其估值